CBD pharmacy

In 2025, CBD in pharmacies is experiencing a quiet yet powerful revolution. Once relegated to the margins of wellness, cannabidiol (CBD) is now establishing itself in French pharmacies as a credible, regulated, and most importantly, accessible natural alternative. But what does the current regulation say? What products can truly be found in a pharmacy? And above all, why are so many people turning to CBD today? This comprehensive guide, based on the latest publications from 2025, answers all your questions.

The new rules of the game: what CBD regulation says in 2025

A harmonized THC threshold of 0.3% throughout the European Union

Since 2025, European regulations have taken a decisive turn with the introduction of a uniform 0.3% THC threshold for all finished products containing CBD, whether food, cosmetic, or wellness-oriented. This measure harmonizes practices among EU countries and prevents confusion between legal products and illicit substances.

To learn more about these regulatory changes, you can consult this detailed article on the subject.

Clear distinction between medical cannabis and wellness CBD

Another major advance: regulation now clearly distinguishes between CBD derived from industrial hemp (without psychoactive effects) and medical cannabis containing THC, prescribed within a strict medical framework. This clarification allows pharmacies to offer CBD products without fear of breaking the law, while reassuring consumers.

France-EU alignment: an opening for pharmacies

Thanks to this regulatory alignment, French pharmacies can legally offer CBD oils, dried flowers, cosmetics, and food supplements, provided these products comply with European standards. Large retailers are also starting to show interest, but pharmacies retain the advantage of personalized advice.

CBD pharmacy: the problems it solves in 2025

Ending the confusion between drug and wellness

Until recently, CBD suffered from a blurred image, often associated with recreational cannabis. In 2025, the European directive puts an end to this confusion. CBD-based products are now clearly identified, traceable, and separate from psychoactive substances. The result: easier access in pharmacies, without stigma.

Addressing the partial failure of widespread medical cannabis use

While the widespread use of medical cannabis in France remains in a transitional phase (January 2025 to March 2026), THC-free CBD oils offer an immediate solution for patients seeking relief. They help support this crucial period while avoiding THC-related side effects.

A comprehensive report is available on this specialized site.

Limiting the risks of the parallel market

With enhanced labeling, traceability controls, and the 0.3% THC limit, CBD products sold in pharmacies offer a level of safety not always guaranteed by the parallel market. By purchasing in pharmacies, users avoid adulterated or incorrectly dosed products.

Reducing drug interactions

Pharmacists play a key role in advising on CBD. In 2025, they are trained to identify potential interactions with treatments such as antihypertensives, anticoagulants, or antidiabetics. This personalized monitoring is a major asset of the pharmaceutical channel.

Concrete benefits for users

A tailor-made wellness solution

CBD oils available in pharmacies in 2025 come in several concentrations. Whether for improving sleep, reducing stress, or relieving chronic pain, everyone can find a suitable product, without psychoactive effects and without a prescription.

To learn more about CBD accessibility in pharmacies, consult this Chanvrery article.

Safe, traceable, and tested products

Every CBD product in pharmacies is accompanied by laboratory analyses, guaranteeing the absence of contaminants and compliance with the legal THC level. This transparency reassures users and promotes regular consumption, with full confidence.

Continuity of care during the transition phase

For patients who participated in the medical cannabis experiment, the transition period until March 2026 is crucial. Pharmacies offer both pure CBD products for daily use and solutions combining THC and CBD on medical prescription.

Concrete use cases in 2025

Oils, flowers, and cosmetics in pharmacies

In pharmacies, one now finds full-spectrum oils, dried flowers for vaporization, as well as creams and balms for local application. All these products comply with the 0.3% THC threshold and are derived from varieties authorized by the European Union.

Regulated medical treatment for certain patients

Patients suffering from serious pathologies can benefit from treatments based on dried flowers or oils combining CBD and THC, by prescription. These treatments are dispensed exclusively in pharmacies, as part of post-experimentation continuity.

A natural alternative for daily life

More and more French people are opting for over-the-counter CBD to manage their stress or improve their sleep. This phenomenon is accompanied by a change in mentality: CBD is no longer seen as a fad, but as a real wellness solution, validated by healthcare professionals.

Key figures for the French market in 2025

A rapidly growing market

The CBD market in France is estimated at 900 million euros by the end of 2025. This growth is driven by the popularity of sleep oils, relaxing lozenges, cosmetics, and THC-free vape devices, all available in pharmacies or specialized stores.

A stabilized legal framework

With a THC level capped at 0.3% and reinforced controls, CBD products benefit from a clear legal framework, conducive to consumer confidence and the growth of the pharmaceutical sector.

Most frequently asked questions in December 2025

What CBD products can be bought in pharmacies?

Pharmacies offer products containing less than 0.3% THC, derived from EU-authorized varieties. Labels clearly indicate the cannabinoids present (CBD, CBG, CBN). It is advisable to check the composition before purchase.

Is CBD accessible without a prescription?

Yes. In 2025, many CBD-based products are available over-the-counter in pharmacies, including oils, herbal teas, creams, and food supplements.

For more details, you can consult our dedicated FAQ.

Are there risks of interaction with medications?

Yes, in some cases. It is recommended to consult a pharmacist, especially if you are undergoing treatment for hypertension, diabetes, or blood clotting.

Official information is available on the ARS Occitanie website.

What is the difference between CBD and medical cannabis?

CBD is extracted from industrial hemp and used for wellness, without psychoactive effects. Medical cannabis, on the other hand, contains THC and requires a prescription. Both are governed by distinct regulations.

News and trends from the week of December 11 to 18, 2025

Although no major publications were released this week, general trends confirm the France-EU alignment on the THC threshold, the gradual integration of medical cannabis into the pharmacopoeia, and the growth of the CBD market. Over-the-counter accessibility in pharmacies remains a central topic, strengthening CBD's position as a natural and regulated alternative.

To delve deeper into these trends, you can read our article on modern phytotherapy and cannabinoids.

CBD in pharmacies intrigues, reassures, and questions. In December 2025, searches explode around a single need: to understand if, how, and why cannabidiol is available in pharmacies. Practical questions, legitimate doubts, and a desire to consume safely. Here is a complete analysis of current trends surrounding the query "CBD pharmacy," to answer all the questions of consumers and healthcare professionals.

Is CBD sold in pharmacies in France?

Yes, but under certain conditions. In France, CBD is available in pharmacies, mainly in the form of food supplements, oils, capsules, or cosmetics. However, these products must not contain more than 0.3% THC, in accordance with European regulations. This point remains unclear for many consumers, hence the growing interest in reliable information provided by pharmacists.

The pharmacist's role then becomes central: they reassure, guide, and advise. Much like a mountain guide in a regulatory fog. Patients want clarity, and the pharmacy remains a trusted landmark.

Prescription required or free access?

Confusion persists between wellness CBD and medical cannabis. For CBD-based products sold in pharmacies, no prescription is necessary. However, for therapeutic cannabis, used for severe pathologies (epilepsy, chronic pain, etc.), a medical prescription is mandatory. This product is dispensed only in hospital pharmacies or authorized pharmacies.

The end of the national experiment in 2024 paved the way for an anticipated regularization in 2025, with the first marketing authorizations (AMMs) underway. A turning point that fuels research, as shown by this article from Le Quotidien du Pharmacien.

What CBD products are available in pharmacies?

In 2025, the offer has greatly diversified. One primarily finds:

Sublingual oils, dosed between 5% and 30% CBD
Extended-release capsules
Creams and balms for local application
Oral or nasal sprays

Pharmacies prioritize products with batch analyses (COA), European hemp origin, and complete traceability. A quality requirement that reassures consumers, especially given the numerous, sometimes dubious, online offers. For those who wish to delve deeper, the CBD.fr website offers an analysis of the most frequent searches around CBD this year.

Is CBD in pharmacies controlled?

Yes. Products available in pharmacies are subject to strict controls, even if they are not considered medicines. Laboratories must provide Certificates of Analysis (COA), prove the absence of THC beyond legal thresholds, and demonstrate the safety of their formulations.

Pharmacists themselves are increasingly trained in reading these technical documents. This allows them to best advise patients, particularly on possible drug interactions.

The pharmacist's role in support

The pharmacist is no longer just a dispenser. They become a true advisor in phytotherapy and cannabinoids. They can guide according to needs (sleep, anxiety, pain), suggest an adapted dosage, and warn about contraindications (anticoagulants, antiepileptics, etc.).

This need for support is also at the heart of consumer expectations, as highlighted in this article on CBD legalization.

The most frequent doubts and objections

Despite the democratization of CBD, some concerns persist:

Is it really legal? Yes, as long as the THC level is below 0.3%.
Can you test positive for a drug test? Very unlikely with well-formulated products, but not impossible with excessive consumption.
Are the effects proven? Serious studies are multiplying, particularly on anxiety, sleep, and chronic pain.
Is the price justified? Yes, in pharmacies, the extra cost is explained by quality, traceability, and personalized advice.

Beginners or experts: who is looking for what?

In 2025, the majority of searches are made by beginners. They want to understand the legislation, know if CBD is safe, and how to consume it properly. But a minority of informed users are already interested in molecules like CBG or CBC, or full-spectrum formulations.

Pharmacies must therefore adapt their discourse: clear and reassuring for novices, more technical for connoisseurs.

New concerns since September 2025

Since autumn, new questions have emerged:

Are alternative cannabinoids like CBG or HHC safe?
How to verify certificates of analysis?
Can products sold outside pharmacies still be trusted?
Will medical cannabis be reimbursed in 2026?

These questions reflect a growing maturity of the market. Consumers want serious, medical, traceable products. A phenomenon already analyzed in this post on the evolution of the CBD market.

Tips for choosing your CBD in pharmacies

Here are some benchmarks for making an informed choice:

Always check for the presence of a COA (Certificate of Analysis).
Prioritize products based on European hemp.
Ask your pharmacist for advice, especially if you are taking other medications.
Start with low dosages and observe the effects.
Avoid impulsive purchases from uncertified sites.

To go further, you can consult our complete guide to CBD in pharmacies.